Skip to main content
. 2010 May 18;21(10):1657–1680. doi: 10.1007/s00198-010-1223-4

Table 2.

Effect on nonvertebral/hip fracture rates (from randomized controlled trials)

Nonvertebral Hip
Osteoporosis (without prevalent vertebral fractures) Established osteoporosis (with prevalent vertebral fractures) Osteoporosis (without prevalent vertebral fractures) Established osteoporosis (with prevalent vertebral fractures)
Raloxifene NA NA NA
Alendronate NA
Risedronate NA NA
Ibandronate NA NA NA
Zoledronate NA NA
Teriparatide NA NA NA
Strontium Ranelate
Denosumab NA NA

NA no evidence available

■ Denotes a preplanned analysis in the entire study population

▲ Denotes a preplanned analysis on a subset of the study population

● Denotes a post hoc analysis